HIO vs JRI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
HIO exhibits a stable financial foundation with a Piotroski F-Score of 5/9, and it currently trades at a discount to both its Graham Number ($5.07) and Intrinsic Value ($4.65). However, the fund's dividend profile is highly alarming, with a payout ratio of 152.14%, indicating that distributions are not being covered by earnings. While valuation metrics are attractive (P/B of 0.90), negative revenue growth and a completely bearish technical trend suggest significant headwinds. The asset appears undervalued on a balance sheet basis but carries high risk regarding dividend sustainability.
The deterministic health profile for JRI is critically weak, highlighted by a Piotroski F-Score of 1/9, indicating severe fundamental deterioration. While the fund offers an attractive dividend yield of 12.51%, the 90% payout ratio suggests limited sustainability and potential capital erosion. The current price of $12.81 trades at a premium to the growth-based intrinsic value of $12.32, and the technical trend is completely bearish (0/100). Overall, the combination of poor financial health scores and negative price momentum outweighs the high yield.
Compare Another Pair
Related Comparisons
HIO vs JRI: Head-to-Head Comparison
This page compares Western Asset High Income Opportunity Fund Inc. (HIO) and Nuveen Real Asset Income and Growth Fund (JRI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.